Future Research

You are here: Simmaron ResearchFuture Research



Simmaron is raising funds for studies to scientifically redefine ME/CFS. Your contributions will expand our ability to execute the strong scientific leads we have.


Data Extraction Studies

Simmaron has unparalleled data from clinical experience monitoring immune testing and utilizing immune-based treatments. We seek funding to extract and statistically analyze clinical experience with treatments, such as Ampligen, to publish data that will stimulate more clinical trials in ME/CFS.

Collaborators:  Sierra Internal Medicine.

Cost: $100,000 for 2015-2016.


Assessment of the Prevalence of Clonal T-cell Receptor Gamma Gene Rearrangements in CFS Patients with Herpes Virus Infections

500px-1FYT_T-cell_receptor_and_HLA_class_II_complexSimmaron will assess the diagnostic and prognostic potential value of analyzing CFS/ME patients for T-cell receptor gamma clonality. As CFS/ME is associated with increased incidence of lymphoma and certain other cancers, this study will investigate the value of T-cell gene rearrangements in identifying a subset of patients who are at risk of developing cancer, for diagnostic and treatment purposes.

Collaborators:  University of Nevada, Reno, Sierra Internal Medicine.

Cost:  $152,000


Donate as we scientifically redefine ME/CFS!

*Simmaron Research supports 10% indirect costs in funded projects.